Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Net Insight AB in the divestment of the Streaming Solution business area (Sye) to a Fortune 500 company
Mandate

Vinge has advised Net Insight AB in the divestment of the Streaming Solution business area (Sye) to a Fortune 500 company

January 30, 2020 Capital Markets and Public M&A

With the close of the transaction, 100% of the shares in the wholly owned Sye business subsidiary, all relevant IPRs and contracts and about 30 employees and consultants have been transferred to the acquirer.

Vinge’s team consisted of partners Kristina Ekberg and Jesper Schönbeck together with, among others, Johanna Wiberg (M&A), Stojan Arnerstål (IP) and Maria Schultzberg (tax).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026